CRESS | $234,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Certified by Founder
Lodge
Biorithm
start up
Singapore
- Singapore
- 19/12/2023
- Series A
- $3,500,000
By leading a new standard of maternity care, Biorithm aims to end preventable pregnancy complications & stillbirth through predictive and precision medicine.
Forging new frontiers in women's health and pregnancy care to improve outcomes globally, we have developed cutting-edge analytic software together with medical-grade wearables for accurate monitoring of a wide range of pregnancy data.
Founded by doctors & engineers, Biorithm is a medical technology company, spun off from Nanyang Technological University Singapore (NTU).
- Industry Medical Device
- Website https://www.bio-rithm.com/
- LinkedIn https://www.linkedin.com/company/biorithm/about/
Related People
Amrish NairFounder
Singapore -
Singapore
Signal processing engineer with a focus on sparse sampling and biomedical applications. Experience with academia and interdisciplinary research with clinicians.
QuSecure | $28,000,000 | (Feb 21, 2025)
AheadComputing | $21,500,000 | (Feb 21, 2025)
Together AI | $30,000,000 | (Feb 21, 2025)
Kodesage | $2,300,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
Oso Semiconductor | $5,200,000 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
Pinkfish | $7,600,000 | (Feb 21, 2025)
Esperto Medical | Undisclosed Amount | (Feb 21, 2025)